Akebia Therapeutics CEO On Controlling Anemia Safely

By: via Benzinga
Akebia Therapeutics Inc (NASDAQ: AKBA) is developing a safer treatment for anemia in patients with Chronic Kidney Disease. The ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.